Skip to content

Clinical trials

Phase 4 Cardiovascular Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 4 Country / region: Canada Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20041
20051
20062
20071
20081
20094
20111
20124
20144
20171
20181
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status6
Recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hamilton Health Sciences Corporation3
University Health Network, Toronto3
Canadian Medical and Surgical Knowledge Translation Research Group2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
Ottawa Heart Institute Research Corporation2
Unity Health Toronto2
University of Saskatchewan2
AstraZeneca1
Boehringer Ingelheim1
Drahomir Aujesky1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases31
Stroke6
Myocardial Infarction5
Diabetes Mellitus4
Diabetes Mellitus, Type 24
Coronary Disease3
Heart Diseases3
Hypertension3
Obesity3
Acute Coronary Syndrome2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.